Zalcitabine - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for zalcitabine and what is the scope of patent protection?
Zalcitabine
is the generic ingredient in one branded drug marketed by Roche and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for zalcitabine
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 116 |
Clinical Trials: | 49 |
Patent Applications: | 6,686 |
Formulation / Manufacturing: | see details |
DailyMed Link: | zalcitabine at DailyMed |
Recent Clinical Trials for zalcitabine
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Avexa | Phase 3 |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 2/Phase 3 |
National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2/Phase 3 |
Medical Subject Heading (MeSH) Categories for zalcitabine
Anatomical Therapeutic Chemical (ATC) Classes for zalcitabine
US Patents and Regulatory Information for zalcitabine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | HIVID | zalcitabine | TABLET;ORAL | 020199-002 | Jun 19, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | HIVID | zalcitabine | TABLET;ORAL | 020199-001 | Jun 19, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for zalcitabine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Roche | HIVID | zalcitabine | TABLET;ORAL | 020199-002 | Jun 19, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Roche | HIVID | zalcitabine | TABLET;ORAL | 020199-001 | Jun 19, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Roche | HIVID | zalcitabine | TABLET;ORAL | 020199-002 | Jun 19, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |